trim63 Search Results


99
Thermo Fisher gene exp trim63 mm01185221 m1
Gene Exp Trim63 Mm01185221 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp trim63 mm01185221 m1/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
gene exp trim63 mm01185221 m1 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

92
R&D Systems bsa solution
Bsa Solution, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bsa solution/product/R&D Systems
Average 92 stars, based on 1 article reviews
bsa solution - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

99
Thermo Fisher gene exp trim63 rn00590197 m1
Gene Exp Trim63 Rn00590197 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp trim63 rn00590197 m1/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
gene exp trim63 rn00590197 m1 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

86
Thermo Fisher gene exp trim63 hs00261590 m1
Gene Exp Trim63 Hs00261590 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp trim63 hs00261590 m1/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
gene exp trim63 hs00261590 m1 - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

96
Proteintech anti murf1
Anti Murf1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti murf1/product/Proteintech
Average 96 stars, based on 1 article reviews
anti murf1 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

99
Bio-Techne corporation anti murf1
Sarcopenic features of myotubes differentiated from senescent SYUIQ-5 treated myoblasts. ( A ) Representative western blot images of <t>MURF1</t> and ATROGIN-1 proteins expressed in myotubes lysates differentiated for 7 d from SYUIQ-5 untreated (NT) or treated (0.4 μM and 1.0 μM) myoblasts and relative histograms of protein levels quantification normalized on VINCULIN (MURF1 histogram: n = 5–7, NT vs 1.0 μM ** p = .059, 1-way ANOVA Tukey’s multiple comparison test; ATROGIN-1 histogram: n = 6, NT vs 1.0 μM * p = .0370, 1-way ANOVA Tukey’s multiple comparison test). ( B ) Representative western blot images of TOTAL UBIQUITIN protein expressed in myotubes differentiated for 7 d from SYUIQ-5 untreated (NT) or treated (1.0 μM) myoblasts and relative histogram of protein levels quantification normalized on β-ACTIN ( n = 3, NT vs 1.0 μM * p = .0395, unpaired t test). ( C ) Representative confocal images of myotubes differentiated for 7 d from SYUIQ-5 untreated (NT) or treated (0.4 μM and 1.0 μM) myoblasts and incubated with MitoTracker (red channel) before being fixed. Cells have been immunolabeled with anti-MyHC (green channel) to select differentiated myoblasts and nuclei have been stained with DAPI (blue channel). Objective 20×, scale bar 20 μM. Histogram referred to mitochondria content measured as mean fluorescence intensity signal of MitoTracker ( n = 47–128, NT vs 0.4 μM **** p < .0001, NT vs 1.0 μM **** p < .0001, 0.4 μM vs 1.0 μM * p = .0423, Kruskal–Wallis Dunn’s multiple comparison test). ( D ) Histogram of MYOSTATIN quantification in supernatant of myotubes differentiated from nontreated myoblasts (NT) and from myoblasts treated with 0.4 μM and 1.0 μM of SYUIQ-5. MYOSTATIN levels are expressed as pg/ml and detected by ELISA assay ( n = 5, NT vs 1.0 μM * p = .0226, 1-way ANOVA Tukey’s multiple comparison test).
Anti Murf1, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti murf1/product/Bio-Techne corporation
Average 99 stars, based on 1 article reviews
anti murf1 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

92
Cusabio protein 28 trim28 kits
The Up-Regulated and Down-Regulated Top 5 Proteins Between the Two Groups
Protein 28 Trim28 Kits, supplied by Cusabio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protein 28 trim28 kits/product/Cusabio
Average 92 stars, based on 1 article reviews
protein 28 trim28 kits - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

87
Thermo Fisher gene exp trim63 hs00822397 m1
The Up-Regulated and Down-Regulated Top 5 Proteins Between the Two Groups
Gene Exp Trim63 Hs00822397 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 87/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp trim63 hs00822397 m1/product/Thermo Fisher
Average 87 stars, based on 1 article reviews
gene exp trim63 hs00822397 m1 - by Bioz Stars, 2026-02
87/100 stars
  Buy from Supplier

95
Thermo Fisher gene exp trim63 mm01188690 m1
The Up-Regulated and Down-Regulated Top 5 Proteins Between the Two Groups
Gene Exp Trim63 Mm01188690 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp trim63 mm01188690 m1/product/Thermo Fisher
Average 95 stars, based on 1 article reviews
gene exp trim63 mm01188690 m1 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

86
Thermo Fisher gene exp trim63 cf02649993 m1
The Up-Regulated and Down-Regulated Top 5 Proteins Between the Two Groups
Gene Exp Trim63 Cf02649993 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp trim63 cf02649993 m1/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
gene exp trim63 cf02649993 m1 - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

90
Thermo Fisher gene exp trim63 rn01639111 m1
The Up-Regulated and Down-Regulated Top 5 Proteins Between the Two Groups
Gene Exp Trim63 Rn01639111 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp trim63 rn01639111 m1/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
gene exp trim63 rn01639111 m1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Sarcopenic features of myotubes differentiated from senescent SYUIQ-5 treated myoblasts. ( A ) Representative western blot images of MURF1 and ATROGIN-1 proteins expressed in myotubes lysates differentiated for 7 d from SYUIQ-5 untreated (NT) or treated (0.4 μM and 1.0 μM) myoblasts and relative histograms of protein levels quantification normalized on VINCULIN (MURF1 histogram: n = 5–7, NT vs 1.0 μM ** p = .059, 1-way ANOVA Tukey’s multiple comparison test; ATROGIN-1 histogram: n = 6, NT vs 1.0 μM * p = .0370, 1-way ANOVA Tukey’s multiple comparison test). ( B ) Representative western blot images of TOTAL UBIQUITIN protein expressed in myotubes differentiated for 7 d from SYUIQ-5 untreated (NT) or treated (1.0 μM) myoblasts and relative histogram of protein levels quantification normalized on β-ACTIN ( n = 3, NT vs 1.0 μM * p = .0395, unpaired t test). ( C ) Representative confocal images of myotubes differentiated for 7 d from SYUIQ-5 untreated (NT) or treated (0.4 μM and 1.0 μM) myoblasts and incubated with MitoTracker (red channel) before being fixed. Cells have been immunolabeled with anti-MyHC (green channel) to select differentiated myoblasts and nuclei have been stained with DAPI (blue channel). Objective 20×, scale bar 20 μM. Histogram referred to mitochondria content measured as mean fluorescence intensity signal of MitoTracker ( n = 47–128, NT vs 0.4 μM **** p < .0001, NT vs 1.0 μM **** p < .0001, 0.4 μM vs 1.0 μM * p = .0423, Kruskal–Wallis Dunn’s multiple comparison test). ( D ) Histogram of MYOSTATIN quantification in supernatant of myotubes differentiated from nontreated myoblasts (NT) and from myoblasts treated with 0.4 μM and 1.0 μM of SYUIQ-5. MYOSTATIN levels are expressed as pg/ml and detected by ELISA assay ( n = 5, NT vs 1.0 μM * p = .0226, 1-way ANOVA Tukey’s multiple comparison test).

Journal: The Journals of Gerontology Series A: Biological Sciences and Medical Sciences

Article Title: Murine Myoblasts Exposed to SYUIQ-5 Acquire Senescence Phenotype and Differentiate into Sarcopenic-Like Myotubes, an In Vitro Study

doi: 10.1093/gerona/glae022

Figure Lengend Snippet: Sarcopenic features of myotubes differentiated from senescent SYUIQ-5 treated myoblasts. ( A ) Representative western blot images of MURF1 and ATROGIN-1 proteins expressed in myotubes lysates differentiated for 7 d from SYUIQ-5 untreated (NT) or treated (0.4 μM and 1.0 μM) myoblasts and relative histograms of protein levels quantification normalized on VINCULIN (MURF1 histogram: n = 5–7, NT vs 1.0 μM ** p = .059, 1-way ANOVA Tukey’s multiple comparison test; ATROGIN-1 histogram: n = 6, NT vs 1.0 μM * p = .0370, 1-way ANOVA Tukey’s multiple comparison test). ( B ) Representative western blot images of TOTAL UBIQUITIN protein expressed in myotubes differentiated for 7 d from SYUIQ-5 untreated (NT) or treated (1.0 μM) myoblasts and relative histogram of protein levels quantification normalized on β-ACTIN ( n = 3, NT vs 1.0 μM * p = .0395, unpaired t test). ( C ) Representative confocal images of myotubes differentiated for 7 d from SYUIQ-5 untreated (NT) or treated (0.4 μM and 1.0 μM) myoblasts and incubated with MitoTracker (red channel) before being fixed. Cells have been immunolabeled with anti-MyHC (green channel) to select differentiated myoblasts and nuclei have been stained with DAPI (blue channel). Objective 20×, scale bar 20 μM. Histogram referred to mitochondria content measured as mean fluorescence intensity signal of MitoTracker ( n = 47–128, NT vs 0.4 μM **** p < .0001, NT vs 1.0 μM **** p < .0001, 0.4 μM vs 1.0 μM * p = .0423, Kruskal–Wallis Dunn’s multiple comparison test). ( D ) Histogram of MYOSTATIN quantification in supernatant of myotubes differentiated from nontreated myoblasts (NT) and from myoblasts treated with 0.4 μM and 1.0 μM of SYUIQ-5. MYOSTATIN levels are expressed as pg/ml and detected by ELISA assay ( n = 5, NT vs 1.0 μM * p = .0226, 1-way ANOVA Tukey’s multiple comparison test).

Article Snippet: The following primary antibodies were used: anti-TUBULIN (1:400, #T4026 Merck); anti-phosphorylated H2AX (Ser139, ƴ-H2AX, 1:800, #2577 Cell Signaling Technologies); anti-MyHC (1:200, #MAB4470, Bio-Techne); anti-MURF1 (1:200, #AF5366, Bio-techne); anti-ATROGIN1 (1:100, #AM3141, ECM Biosciences).

Techniques: Western Blot, Comparison, Incubation, Immunolabeling, Staining, Fluorescence, Enzyme-linked Immunosorbent Assay

The Up-Regulated and Down-Regulated Top 5 Proteins Between the Two Groups

Journal: Journal of Inflammation Research

Article Title: Serum Proteomic Analysis Revealed Biomarkers for Eosinophilic Chronic Rhinosinusitis with Nasal Polyps Pathophysiology

doi: 10.2147/JIR.S444280

Figure Lengend Snippet: The Up-Regulated and Down-Regulated Top 5 Proteins Between the Two Groups

Article Snippet: Mannose receptor C-type 1 (MRC1) kits (Cat: CSB-E09961h), cadherin 13 (CDH13) kits (Cat: CSB-E13817h), cluster of differentiation 5 antigen-like (CD5L) kits (Cat: CSB-E13423h), matrix metalloproteinase-2 (MMP2) kits (Cat: CSB-E04675h), plasma protease C1 inhibitor (SERPING1) kits (Cat: CSB-EL021086HU), insulin-like growth factor-binding protein 5 (IGFBP5) kits (Cat: CSB-EL010901HU), tripartite motif-containing protein 28 (TRIM28) kits (Cat: CSB-EL024502HU), and fatty acid-binding protein 5 (FABP5) kits (Cat: CSB-EL007946HU) were purchased from Cusabio (Wuhan, China).

Techniques: Clinical Proteomics

Validation of the top 5 up and down-regulated proteins in an independent validation cohort. ( A – E ) comparison of serum MRC1, CDH13, LTA4H, CD5L and MMP2 concentrations between the eCRSwNP and neCRSwNP groups. ( F – J ) comparison of serum SERPING1, IGFBP5, TRIM28, CHL1 and FABP5 levels between the eCRSwNP and neCRSwNP groups. *P<0.05; **P<0.01; ***P<0.001.

Journal: Journal of Inflammation Research

Article Title: Serum Proteomic Analysis Revealed Biomarkers for Eosinophilic Chronic Rhinosinusitis with Nasal Polyps Pathophysiology

doi: 10.2147/JIR.S444280

Figure Lengend Snippet: Validation of the top 5 up and down-regulated proteins in an independent validation cohort. ( A – E ) comparison of serum MRC1, CDH13, LTA4H, CD5L and MMP2 concentrations between the eCRSwNP and neCRSwNP groups. ( F – J ) comparison of serum SERPING1, IGFBP5, TRIM28, CHL1 and FABP5 levels between the eCRSwNP and neCRSwNP groups. *P<0.05; **P<0.01; ***P<0.001.

Article Snippet: Mannose receptor C-type 1 (MRC1) kits (Cat: CSB-E09961h), cadherin 13 (CDH13) kits (Cat: CSB-E13817h), cluster of differentiation 5 antigen-like (CD5L) kits (Cat: CSB-E13423h), matrix metalloproteinase-2 (MMP2) kits (Cat: CSB-E04675h), plasma protease C1 inhibitor (SERPING1) kits (Cat: CSB-EL021086HU), insulin-like growth factor-binding protein 5 (IGFBP5) kits (Cat: CSB-EL010901HU), tripartite motif-containing protein 28 (TRIM28) kits (Cat: CSB-EL024502HU), and fatty acid-binding protein 5 (FABP5) kits (Cat: CSB-EL007946HU) were purchased from Cusabio (Wuhan, China).

Techniques: Biomarker Discovery, Comparison

ROC curves evaluating the discriminative abilities of candidate proteins for eCRSwNP. ( A ) MRC1, ( B ) CDH13, ( C ) MMP2, ( D ) TRIM28.

Journal: Journal of Inflammation Research

Article Title: Serum Proteomic Analysis Revealed Biomarkers for Eosinophilic Chronic Rhinosinusitis with Nasal Polyps Pathophysiology

doi: 10.2147/JIR.S444280

Figure Lengend Snippet: ROC curves evaluating the discriminative abilities of candidate proteins for eCRSwNP. ( A ) MRC1, ( B ) CDH13, ( C ) MMP2, ( D ) TRIM28.

Article Snippet: Mannose receptor C-type 1 (MRC1) kits (Cat: CSB-E09961h), cadherin 13 (CDH13) kits (Cat: CSB-E13817h), cluster of differentiation 5 antigen-like (CD5L) kits (Cat: CSB-E13423h), matrix metalloproteinase-2 (MMP2) kits (Cat: CSB-E04675h), plasma protease C1 inhibitor (SERPING1) kits (Cat: CSB-EL021086HU), insulin-like growth factor-binding protein 5 (IGFBP5) kits (Cat: CSB-EL010901HU), tripartite motif-containing protein 28 (TRIM28) kits (Cat: CSB-EL024502HU), and fatty acid-binding protein 5 (FABP5) kits (Cat: CSB-EL007946HU) were purchased from Cusabio (Wuhan, China).

Techniques:

ROC Curves of Serum Proteins in Predicting eCRSwNP

Journal: Journal of Inflammation Research

Article Title: Serum Proteomic Analysis Revealed Biomarkers for Eosinophilic Chronic Rhinosinusitis with Nasal Polyps Pathophysiology

doi: 10.2147/JIR.S444280

Figure Lengend Snippet: ROC Curves of Serum Proteins in Predicting eCRSwNP

Article Snippet: Mannose receptor C-type 1 (MRC1) kits (Cat: CSB-E09961h), cadherin 13 (CDH13) kits (Cat: CSB-E13817h), cluster of differentiation 5 antigen-like (CD5L) kits (Cat: CSB-E13423h), matrix metalloproteinase-2 (MMP2) kits (Cat: CSB-E04675h), plasma protease C1 inhibitor (SERPING1) kits (Cat: CSB-EL021086HU), insulin-like growth factor-binding protein 5 (IGFBP5) kits (Cat: CSB-EL010901HU), tripartite motif-containing protein 28 (TRIM28) kits (Cat: CSB-EL024502HU), and fatty acid-binding protein 5 (FABP5) kits (Cat: CSB-EL007946HU) were purchased from Cusabio (Wuhan, China).

Techniques: